Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American …

M Chacón-Diaz, P Custodio-Sánchez… - BMC Cardiovascular …, 2022 - Springer
Objective The primary percutaneous coronary intervention (PPCI) is the preferred
reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). The …

Reperfusion strategy of ST-elevation myocardial infarction: a meta-analysis of primary percutaneous coronary intervention and pharmaco-invasive therapy

K Li, B Zhang, B Zheng, Y Zhang, Y Huo - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Background Pharmaco-invasive therapy (PIT), combining thrombolysis and percutaneous
coronary intervention, was a potential complement for primary percutaneous coronary …

Pharmacoinvasive strategy versus primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients≥ 70 years of age

V Auffret, C Laurin, G Leurent, R Didier, E Filippi… - The American journal of …, 2020 - Elsevier
The benefit-risk ratio of a pharmacoinvasive strategy (PI) in patients≥ 70 years of age with
ST-segment elevation myocardial infarction (STEMI) remains uncertain resulting in its limited …

Terapi Reperfusi pada Infark Miokard dengan ST-Elevasi

HA Bambari, AL Panda, VFF Joseph - e-CliniC, 2021 - ejournal.unsrat.ac.id
Infark miokard diklasifikasikan atas ST-segment elevation myocardial infarction (STEMI) dan
Non-ST-segment elevation myocardial infarction (NSTEMI). Pada pasien STEMI diper …

Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic

M Zuo, S Xiang, S Bhattacharyya, Q Chen… - BMC Cardiovascular …, 2022 - Springer
Background The COVID-19 outbreak represents a significant challenge to international
health. Several studies have reported a substantial decrease in the number of patients …

[HTML][HTML] Clinical competence in ST-segment elevation myocardial infarction management by recently graduated physicians applying for a medical residency program

US Aimoli, CH Miranda - Arquivos Brasileiros de Cardiologia, 2020 - SciELO Brasil
Background: A significant reduction in the morbidity and mortality related to ST-segment
elevation myocardial infarction (STEMI) has been achieved with the development of …

Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction: Insights From the COMPLETE …

P Dehghani, WJ Cantor, J Wang, DA Wood… - Circulation …, 2021 - Am Heart Assoc
Background: The COMPLETE trial (Complete Versus Culprit-Only Revascularization to Treat
Multi-Vessel Disease After Early PCI for STEMI) demonstrated that staged nonculprit lesion …

Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia

A Guy, N Gabers, C Crisfield, J Helmer… - BMJ Open …, 2021 - bmjopenquality.bmj.com
Coronary artery disease is the second leading cause of death in Canada. Time to treatment
in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality …

[HTML][HTML] Time-Dependent Risk for Recurrence in Survivors of Major Adverse Cardiovascular Events

A Bermon, B Trejo-Valdivia, CFM Castaño, AM Segura… - Cureus, 2024 - ncbi.nlm.nih.gov
Introduction: The prevalence of the population with a history of an occlusive cardiovascular
event has been increasing in recent years, which means that a large number of patients will …

[HTML][HTML] Фармакоинвазивный подход в лечении острого инфаркта миокарда: современное состояние вопроса

АС Терещенко, ТМ Ускач… - Российский …, 2021 - cyberleninka.ru
Существующие клинические рекомендации выделяют два основных подхода к
лечению пациентов с инфарктом миокарда с подъемом сегмента ST: стратегию …